Home  >  Products  >  TNNT2 (troponin T type 2 (cardiac)) Blocking Peptide (the N terminal of protein) (100ug)
TNNT2 (troponin T type 2 (cardiac)) Blocking Peptide (the N terminal of protein) (100ug)

TNNT2 (troponin T type 2 (cardiac)) Blocking Peptide (the N terminal of protein) (100ug)

Supplier: Aviva Systems Biology Incorporated
Star_fadedStar_fadedStar_fadedStar_fadedStar_faded
0 reviews | Write a Review Pencil
This is a synthetic peptide designed for use in combination with anti-TNNT2 antibody (Catalogue #: ARP41717_P050) made by Aviva Systems Biology. It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications. Please inquire for more details.
Presku: AAP41717
Size: 100 ug
Weight: 35kDa
Gene: 7139
Format: Lyophilized powder
Target: TNNT2 is the tropomyosin-binding subunit of the troponin complex, which is located on the thin filament of striated muscles and regulates muscle contraction in response to alterations in intracellular calcium ion concentration. Mutations in the gene encoding TNNT2 have been associated with familial hypertrophic cardiomyopathy as well as with dilated cardiomyopathy. The protein encoded by this gene is the tropomyosin-binding subunit of the troponin complex, which is located on the thin filament of striated muscles and regulates muscle contraction in response to alterations in intracellular calcium ion concentration. Mutations in this gene have been associated with familial hypertrophic cardiomyopathy as well as with dilated cardiomyopathy. Transcripts for this gene undergo alternative splicing that results in many tissue-specific isoforms, however, the full-length nature of some of these variants has not yet been determined.
Alternative names: CMH2; CMPD2; MGC3889; TnTC; cTnT
See Full Product Listings >